ASPH


Summary: This gene is thought to play an important role in calcium homeostasis. The gene is expressed from two promoters and undergoes extensive alternative splicing. The encoded set of proteins share varying amounts of overlap near their N-termini but have substantial variations in their C-terminal domains resulting in distinct functional properties. The longest isoforms (a and f) include a C-terminal Aspartyl/Asparaginyl beta-hydroxylase domain that hydroxylates aspartic acid or asparagine residues in the epidermal growth factor (EGF)-like domains of some proteins, including protein C, coagulation factors VII, IX, and X, and the complement factors C1R and C1S. Other isoforms differ primarily in the C-terminal sequence and lack the hydroxylase domain, and some have been localized to the endoplasmic and sarcoplasmic reticulum. Some of these isoforms are found in complexes with calsequestrin, triadin, and the ryanodine receptor, and have been shown to regulate calcium release from the sarcoplasmic reticulum. Some isoforms have been implicated in metastasis. [provided by RefSeq, Sep 2009].

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
aspartate beta-hydroxylaseMIM:600582Ensembl:ENSG00000198363HGNC:HGNC:757PA250568q12.3

Gene Categories:

PROTEASE

GO terms in ASPH


Term TypeEvidence TypeGO Term IDGO Des.
CCIDAGO:0005783endoplasmic reticulum
CCNASGO:0005789endoplasmic reticulum membrane
CCTASGO:0005789endoplasmic reticulum membrane
CCIDAGO:0005886plasma membrane
CCIEAGO:0016021integral component of membrane
CCIDAGO:0032541cortical endoplasmic reticulum
CCIEAGO:0033017sarcoplasmic reticulum membrane
BPTASGO:0006936muscle contraction
BPIEAGO:0007389pattern specification process
BPIEAGO:0008285negative regulation of cell proliferation
BPIEAGO:0022900electron transport chain
BPIEAGO:0031647regulation of protein stability
BPTASGO:0034220ion transmembrane transport
BPIEAGO:0035108limb morphogenesis
BPIEAGO:0042264peptidyl-aspartic acid hydroxylation
BPIDAGO:0045862positive regulation of proteolysis
BPIEAGO:0060021roof of mouth development
BPIEAGO:0060325face morphogenesis
BPIDAGO:0097202activation of cysteine-type endopeptidase activity
BPIEAGO:1901879regulation of protein depolymerization
BPTASGO:1903779regulation of cardiac conduction
MFIEAGO:0004597peptide-aspartate beta-dioxygenase activity
MFTASGO:0005198structural molecule activity
MFNASGO:0005509calcium ion binding
MFIPIGO:0005515protein binding
MFTASGO:0008307structural constituent of muscle
MFTASGO:0009055electron transfer activity

Gene expression in normal tissue: ASPH

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in ASPH


DatabasePathway IDPathway Des.
biocartahifpathwayhypoxia-inducible factor in the cardivascular system
reactomeR-HSA-2672351Stimuli-sensing channels
reactomeR-HSA-382551Transport of small molecules
reactomeR-HSA-397014Muscle contraction
reactomeR-HSA-5576891Cardiac conduction
reactomeR-HSA-5578775Ion homeostasis
reactomeR-HSA-983712Ion channel transport

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD329Merck603
iGMDRD872BRD71373
iGMDRD367Ro 28-16752
iGMDRD147Prima-11
iGMDRD246NPC262
iGMDRD300Tozasertib3
iGMDRD213SMR0000686503
iGMDRD231Importazole3
iGMDRD219Bax channel blocker4
iGMDRD57Chloropentafluorobenzene2
iGMDRD85Ursolic acid3
iGMDRD607Ubistatin B2
iGMDRD512nutlin 33
iGMDRD560MK-22062
iGMDRD562Navitoclax2
iGMDRD506Fedratinib5
iGMDRD399Selumetinib1
iGMDRD188Piperlongumine3
iGMDRD268Cerulenin3
iGMDRD23Gossypol3
iGMDRD60Quinoclamine3
iGMDRD690PRIMA-1MET6
iGMDRD8024-methylfasudil3
iGMDRD474Avrainvillamide3
iGMDRD247Blebbistatin4
iGMDRD52Rotenone2
iGMDRD226ML0062
iGMDRD8012,4-dideoxy-DC-45-A23
iGMDRD318PAC-15
iGMDRD441TW 373
iGMDRD152179324-69-73
iGMDRD71Sparfosic acid3
iGMDRD446LY 21832403
iGMDRD380Pifithrin-alpha3
iGMDRD466Chaetocin2
iGMDRD425ERASTIN1
iGMDRD772BRD47703
iGMDRD427ABT7372

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in ASPH

​​​​